BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 34445672)

  • 21. Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism.
    Qi C; Zhu Y; Pan J; Usuda N; Maeda N; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    J Biol Chem; 1999 May; 274(22):15775-80. PubMed ID: 10336479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.
    Marrapodi M; Chiang JY
    J Lipid Res; 2000 Apr; 41(4):514-20. PubMed ID: 10744771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
    Reddy JK; Hashimoto T
    Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARalpha.
    Kane CD; Francone OL; Stevens KA
    Gene; 2006 Oct; 380(2):84-94. PubMed ID: 16828988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice.
    Wan YJ; Cai Y; Lungo W; Fu P; Locker J; French S; Sucov HM
    J Biol Chem; 2000 Sep; 275(36):28285-90. PubMed ID: 10866995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis.
    Misra P; Reddy JK
    Biochimie; 2014 Mar; 98():63-74. PubMed ID: 24291192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
    El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
    Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis.
    Misra P; Viswakarma N; Reddy JK
    Subcell Biochem; 2013; 69():77-99. PubMed ID: 23821144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins.
    Schachtrup C; Emmler T; Bleck B; Sandqvist A; Spener F
    Biochem J; 2004 Aug; 382(Pt 1):239-45. PubMed ID: 15130092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
    Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C; Zhu Y; Reddy JK
    Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells.
    Hsu MH; Savas U; Griffin KJ; Johnson EF
    J Biol Chem; 2001 Jul; 276(30):27950-8. PubMed ID: 11371553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of fatty acid transport protein and mitochondrial and peroxisomal beta-oxidation gene expression by fatty acids in developing rats.
    Ouali F; Djouadi F; Merlet-Bénichou C; Riveau B; Bastin J
    Pediatr Res; 2000 Nov; 48(5):691-6. PubMed ID: 11044493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
    Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
    Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver.
    Asayama K; Sandhir R; Sheikh FG; Hayashibe H; Nakane T; Singh I
    Mol Cell Biochem; 1999 Apr; 194(1-2):227-34. PubMed ID: 10391144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs.
    Issemann I; Prince RA; Tugwood JD; Green S
    J Mol Endocrinol; 1993 Aug; 11(1):37-47. PubMed ID: 8240670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
    Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
    J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver.
    Yu S; Cao WQ; Kashireddy P; Meyer K; Jia Y; Hughes DE; Tan Y; Feng J; Yeldandi AV; Rao MS; Costa RH; Gonzalez FJ; Reddy JK
    J Biol Chem; 2001 Nov; 276(45):42485-91. PubMed ID: 11551940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
    Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
    FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.